The CTSB release from LMP could lead to activation of NLRP3 inflammasome and NLRP3-dependent neuronal pyroptosis can result in neurodegenerative diseases such as AD (Olsen and Singhrao, 2016; Li et al., 2018). This evidence concerns the gene NLRP3 and Alzheimer disease.